Exploring erectile aids for transgender men after gender-affirming surgery
Erectile Aid Use in Post-phalloplasty and Post-metoidioplasty Transgender Patients: an Epidemiological Survey
This study looks at how transgender men who have had surgery use erectile aids for sex and whether they and their partners are satisfied with them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University Hospital, Ghent Academic / other |
| Locations | 1 site (Ghent, East-Flanders) |
| Trial ID | NCT06639763 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the experiences of transgender men who have undergone phalloplasty or metoidioplasty, focusing on their use of erectile aids for sexual intercourse. It aims to assess the satisfaction levels of both the patients and their partners regarding these aids, which are often necessary for achieving sexual function post-surgery. By collecting data through questionnaires, the study seeks to document the effectiveness and comfort of various non-surgical aids, filling a significant gap in current medical knowledge. The findings will provide valuable insights for healthcare providers to better support the sexual health needs of transgender patients.
Who should consider this trial
Good fit: Ideal candidates include transgender men aged 18 and older who have undergone phalloplasty or metoidioplasty and are sexually active.
Not a fit: Patients who are not sexually active or who have undergone these surgeries less than six months ago may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the sexual health and satisfaction of transgender men and their partners following gender-affirming surgeries.
How similar studies have performed: While there is limited documentation on the effectiveness of non-surgical erectile aids in this population, the study aims to address an under-researched area, suggesting a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient and partner age ≥ 18 years. * Transgender or gender non-conforming individuals (and their partners). * Patients have undergone phalloplasty or metoidioplasty as a form of genital gender affirming surgery. * ≥6 months after phalloplasty or metoidioplasty (any type of flap or technique is allowed). * Sexually active or has been sexually active since phalloplasty or metoidioplasty with a partner or main sexual partner. * Voluntarily agreed that the data may be used for an anonymized scientific study. Exclusion Criteria: * Patient age \< 18 years. * Cisgender patients treated with phalloplasty or metoidioplasty for various reasons. * \<6 months after phalloplasty or metoidioplasty. * Not sexually active since phalloplasty/metoidioplasty. * Patient and/or partner have no interest in penetrative sexual intercourse.
Where this trial is running
Ghent, East-Flanders
- Department of Urology, University Hospital Ghent — Ghent, East-Flanders, Belgium (Recruiting)
Study contacts
- Principal investigator: Anne-Françoise Spinoit, MD, PhD — University Hospital, Ghent
- Study coordinator: Wietse Claeys, MD
- Email: wietse.claeys@ugent.be
- Phone: 003293322276
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.